Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 1
Neurology Minute
In part one of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss current biomarkers for Alzheimer disease and how do you use them in clinic.
info_outline
Neuroimmunology Update 2025: MOGAD Treatments
Neurology Minute
Dr. Justin Abbatemarco discusses updates around MOGAD treatments. Show references:
info_outline
Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes
Neurology Minute
Dr. Justin Abbatemarco discusses autoimmune encephalitis with a focus on outcomes. Show references:
info_outline
The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting
Neurology Minute
Dr. Halley Alexander discusses the Neurology Today article, “The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting,” by Gina Shaw, available in the latest issue of Neurology Today or at . Show reference:
info_outline
Diagnosis of Alzheimer Disease Using Plasma Biomarkers
Neurology Minute
Dr. Greg Cooper and Dr. Joseph Therriault discuss the use of plasma biomarkers in diagnosing Alzheimer disease. Show reference:
info_outline
Women With Genetic Epilepsies
Neurology Minute
Dr. Halley Alexander and Dr. Paula Marques discuss sex differences in genetically determined epilepsies. Show reference:
info_outline
Neuroimmunology Update 2025: AQP4+ NMOSD Treatment Landscape
Neurology Minute
Dr. Justin Abbatemarco discusses updates around treatments in AQP4+ NMOSD. Show references:
info_outline
BTK Inhibitors in Multiple Sclerosis Treatment - Part 3
Neurology Minute
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how to address questions related to BTK Inhibitors with patients. Show reference:
info_outline
BTK Inhibitors in Multiple Sclerosis Treatment - Part 2
Neurology Minute
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss the clinical trial data available in both the relapsing and progressive cohorts. Show reference:
info_outline
BTK Inhibitors in Multiple Sclerosis Treatment - Part 1
Neurology Minute
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies. Show reference:
info_outlineDr. Svetlana Blitshteyn discusses the best management approach for POTS and its link with viruses like COVID-19.